{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:53:25Z","timestamp":1770526405973,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,14]]},"DOI":"10.7759\/cureus.87902","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:18:39Z","timestamp":1752506319000},"source":"Crossref","is-referenced-by-count":1,"title":["Sublingual Administration of Desmopressin Oral Disintegrating Tablet in a Neonate With Central Diabetes Insipidus"],"prefix":"10.7759","author":[{"given":"Daisuke","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Yagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromune","family":"Narusawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2021.08.087","article-title":"Variability in oral desmopressin dose requirements in children with central diabetes insipidus","volume":"239","author":"Almutlaq N","year":"2021","unstructured":"Almutlaq N, Eugster EA. Variability in oral desmopressin dose requirements in children with central diabetes insipidus. J Pediatr. 2021, 239:228-30. 10.1016\/j.jpeds.2021.08.087","journal-title":"J Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-020-00401-7","article-title":"Pediatric pharmacology of desmopressin in children with enuresis: a comprehensive review","volume":"22","author":"Gasthuys E","year":"2020","unstructured":"Gasthuys E, Dossche L, Michelet R, et al.. Pediatric pharmacology of desmopressin in children with enuresis: a comprehensive review. Paediatr Drugs. 2020, 22:369-83. 10.1007\/s40272-020-00401-7","journal-title":"Paediatr Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/157488607781668891","article-title":"Desmopressin 30 years in clinical use: a safety review","volume":"2","author":"Vande Walle J","year":"2007","unstructured":"Vande Walle J, Stockner M, Raes A, N\u00f8rgaard JP. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf. 2007, 2:232-8. 10.2174\/157488607781668891","journal-title":"Curr Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2015.04.013","article-title":"Management of diabetes insipidus and adipsia in the child","volume":"29","author":"Di Iorgi N","year":"2015","unstructured":"Di Iorgi N, Morana G, Napoli F, Allegri AE, Rossi A, Maghnie M. Management of diabetes insipidus and adipsia in the child. Best Pract Res Clin Endocrinol Metab. 2015, 29:415-36. 10.1016\/j.beem.2015.04.013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1157","article-title":"Buccally administered intranasal desmopressin acetate for the treatment of neurogenic diabetes insipidus in infancy","volume":"101","author":"Smego AR","year":"2016","unstructured":"Smego AR, Backeljauw P, Gutmark-Little I. Buccally administered intranasal desmopressin acetate for the treatment of neurogenic diabetes insipidus in infancy. J Clin Endocrinol Metab. 2016, 101:2084-8. 10.1210\/jc.2016-1157","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2017-0051","article-title":"Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus","volume":"30","author":"Mavinkurve M","year":"2017","unstructured":"Mavinkurve M, McGrath N, Johnston N, Moloney S, Murphy NP, Hawkes CP. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus. J Pediatr Endocrinol Metab. 2017, 30:623-8. 10.1515\/jpem-2017-0051","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14125","article-title":"Intravenous formulation of desmopressin delivered via oral and g tube routes for the treatment of central diabetes insipidus: first experience in infants","volume":"92","author":"Lim WY","year":"2020","unstructured":"Lim WY, Riba-Wolman R. Intravenous formulation of desmopressin delivered via oral and g tube routes for the treatment of central diabetes insipidus: first experience in infants. Clin Endocrinol (Oxf). 2020, 92:179-81. 10.1111\/cen.14125","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-023-00578-7","article-title":"Management of central diabetes insipidus in disabled children with diluted oral desmopressin lyophilisate formulation administered through nasogastric tube: a retrospective case series","volume":"25","author":"Korkmaz HA","year":"2023","unstructured":"Korkmaz HA, Arya VB, G\u00f6n\u00fcll\u00fc A, Co\u015fkunol F, Ozkan B. Management of central diabetes insipidus in disabled children with diluted oral desmopressin lyophilisate formulation administered through nasogastric tube: a retrospective case series. Paediatr Drugs. 2023, 25:595-601. 10.1007\/s40272-023-00578-7","journal-title":"Paediatr Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.16120","article-title":"Desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infants","volume":"12","author":"De Waele K","year":"2014","unstructured":"De Waele K, Cools M, De Guchtenaere A, et al.. Desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infants. Int J Endocrinol Metab. 2014, 12:e16120. 10.5812\/ijem.16120","journal-title":"Int J Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2013-0368","article-title":"Management of central diabetes insipidus with oral desmopressin lyophilisate in infants","volume":"27","author":"Korkmaz HA","year":"2014","unstructured":"Korkmaz HA, Demir K, K\u0131l\u0131\u00e7 FK, Terek D, Arslano\u011flu S, Dizdarer C, Ozkan B. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants. J Pediatr Endocrinol Metab. 2014, 27:923-7. 10.1515\/jpem-2013-0368","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref11","article-title":"Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin","volume":"57","author":"Hanta D","year":"2015","unstructured":"Hanta D, T\u00f6rer B, Temiz F, K\u0131l\u0131\u00e7da\u011f H, G\u00f6k\u00e7e M, Erdo\u011fan O. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin. Turk J Pediatr. 2015, 57:90-3.","journal-title":"Turk J Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.02.039","article-title":"Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction","volume":"185","author":"De Guchtenaere A","year":"2011","unstructured":"De Guchtenaere A, Van Herzeele C, Raes A, Dehoorne J, Hoebeke P, Van Laecke E, Vande Walle J. Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction. J Urol. 2011, 185:2308-13. 10.1016\/j.juro.2011.02.039","journal-title":"J Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.03.015","article-title":"The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis","volume":"178","author":"Robson WL","year":"2007","unstructured":"Robson WL, Leung AK, Norgaard JP. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J Urol. 2007, 178:24-30. 10.1016\/j.juro.2007.03.015","journal-title":"J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18579\/jpcrkc\/2017\/16\/3\/118766","article-title":"Sublingual tablets and the benefits of the sublingual route of administration","volume":"16","author":"Khan AB","year":"2017","unstructured":"Khan AB, Kingsley T, Caroline P. Sublingual tablets and the benefits of the sublingual route of administration. J Pharm Res. 2017, 16:257-67. 10.18579\/jpcrkc\/2017\/16\/3\/118766","journal-title":"J Pharm Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006291838","article-title":"Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults","volume":"46","author":"Osterberg O","year":"2006","unstructured":"Osterberg O, Savic RM, Karlsson MO, Simonsson US, N\u00f8rgaard JP, Walle JV, Agers\u00f8 H. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults. J Clin Pharmacol. 2006, 46:1204-11. 10.1177\/0091270006291838","journal-title":"J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2018.01.009","article-title":"Development and applications of a physiologically-based model of paediatric oral drug absorption","volume":"115","author":"Johnson TN","year":"2018","unstructured":"Johnson TN, Bonner JJ, Tucker GT, Turner DB, Jamei M. Development and applications of a physiologically-based model of paediatric oral drug absorption. Eur J Pharm Sci. 2018, 115:57-67. 10.1016\/j.ejps.2018.01.009","journal-title":"Eur J Pharm Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005282635","article-title":"Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe","volume":"46","author":"Park JY","year":"2006","unstructured":"Park JY, Kim KA, Park PW, Ha JM. Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe. J Clin Pharmacol. 2006, 46:109-14. 10.1177\/0091270005282635","journal-title":"J Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-018-0090-2","article-title":"Finding the right treatment for neonatal abstinence syndrome: is this the right time?","volume":"38","author":"Yen E","year":"2018","unstructured":"Yen E, Davis JM. Finding the right treatment for neonatal abstinence syndrome: is this the right time?. J Perinatol. 2018, 38:785-7. 10.1038\/s41372-018-0090-2","journal-title":"J Perinatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3108","article-title":"Central diabetes insipidus in infancy with or without hypothalamic Adipsic hypernatremia syndrome: early identification and outcome","volume":"101","author":"Djermane A","year":"2016","unstructured":"Djermane A, Elmaleh M, Simon D, Poidvin A, Carel JC, L\u00e9ger J. Central diabetes insipidus in infancy with or without hypothalamic Adipsic hypernatremia syndrome: early identification and outcome. J Clin Endocrinol Metab. 2016, 101:635-43. 10.1210\/jc.2015-3108","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2023.11.012","article-title":"Clinical characteristics of adipsic diabetes insipidus","volume":"30","author":"Yang T","year":"2024","unstructured":"Yang T, Wu W, Liu X, et al.. Clinical characteristics of adipsic diabetes insipidus. Endocr Pract. 2024, 30:141-5. 10.1016\/j.eprac.2023.11.012","journal-title":"Endocr Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/350077-sublingual-administration-of-desmopressin-oral-disintegrating-tablet-in-a-neonate-with-central-diabetes-insipidus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:18:39Z","timestamp":1752506319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/350077-sublingual-administration-of-desmopressin-oral-disintegrating-tablet-in-a-neonate-with-central-diabetes-insipidus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.87902","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,14]]}}}